Endometrial Ablation Market Size, Share, Trends, Industry Analysis Report: By Type (Devices and Procedures), Device Type, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034

The global endometrial ablation market size is expected to reach USD 2,052.22 million by 2034, according to a new study by Polaris Market Research. The report “Endometrial Ablation Market Size, Share, Trends, Industry Analysis Report: By Type (Devices and Procedures), Device Type, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Endometrial ablation is a medical procedure used to treat abnormal uterine bleeding (AUB) by removing or destroying the endometrial lining of the uterus. This treatment is primarily recommended for women who experience heavy or prolonged menstrual periods that do not respond to other treatments, such as hormonal therapies. The procedure aims to reduce or eliminate menstrual bleeding, improving the patient's quality of life. Endometrial ablation is often considered a less invasive alternative to a hysterectomy, allowing for a faster recovery and fewer risks.

The endometrial ablation market growth is driven by several factors, including the increasing prevalence of gynecological disorders such as abnormal uterine bleeding and the rising demand for minimally invasive surgical options. Technological advancements in ablation techniques, such as radiofrequency, cryoablation, and microwave energy, have contributed to the market's growth by improving treatment efficiency and patient outcomes. Additionally, the market is benefiting from the rising awareness of women’s health issues and the growing preference for outpatient procedures that offer shorter recovery times. The endometrial ablation market demand is also rising globally, particularly in emerging markets, where improving healthcare infrastructure and rising disposable incomes are making advanced treatments more accessible.

Endometrial Ablation Market Report Highlights

By type, the devices segment held a larger share of the endometrial ablation market revenue in 2024, primarily driven by the effectiveness and efficiency of the various ablation devices such as radiofrequency and thermal balloon systems. These devices are widely adopted for their proven results in reducing abnormal uterine bleeding with minimal patient recovery time, making them a preferred choice in clinical settings.

By device type, the radiofrequency ablation devices segment dominated the market in 2024 due to their established use in the treatment of abnormal uterine bleeding. Their effectiveness, cost-efficiency, and rapid procedure times contribute to their high adoption rates in both hospitals and outpatient settings.

By end use, ambulatory surgery centers (ASCs) are experiencing the fastest growth rate in the endometrial ablation market. These centers offer a cost-effective, convenient option for patients requiring minimally invasive procedures, with shorter recovery times and reduced hospital stays.

By region, North America dominated the endometrial ablation market share in 2024. This dominance is attributed to a high prevalence of gynecological conditions, advanced healthcare infrastructure, and widespread adoption of innovative medical technologies.

​The endometrial ablation market features several major companies actively offering relevant products and services. A few notable market players include AEGEA Medical, Inc.; AngioDynamics, Inc.; Boston Scientific Corporation; Channel MedSystems; CooperSurgical, Inc.; Hologic, Inc.; Idoman Teoranta; Johnson & Johnson Services, Inc.; Karl Storz; Medtronic plc; Minerva Surgical, Inc.; Olympus Corporation; Omnitech Systems, Inc.; Richard Wolf GmbH; and Veldana Medical SA. ​

Polaris Market Research has segmented the endometrial ablation market report on the basis of type, device type, end use, and region:

By Type Outlook (Revenue-USD Million, 2020–2034)

Devices

Procedures

By Device Type Outlook (Revenue-USD Million, 2020–2034)

Cryoablation

Radiofrequency

Hydrothermal

Thermal Balloon

Microwave energy

Hysteroscopy

By End Use Outlook (Revenue-USD Million, 2020–2034)

Hospitals

Clinics

Ambulatory Surgery Centers

By Regional Outlook (Revenue-USD Million, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

Suth Korea

Indnesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Suth Africa

Rest of Middle East & Africa

Latin America

Mexic

Brazil

Argentina

Rest of Latin America Show more